Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 23708756)

1.

The histone deacetylase inhibitor vorinostat prevents TNFα-induced necroptosis by regulating multiple signaling pathways.

Wang D, Zhao M, Chen G, Cheng X, Han X, Lin S, Zhang X, Yu X.

Apoptosis. 2013 Nov;18(11):1348-62. doi: 10.1007/s10495-013-0866-y.

PMID:
23708756
2.

Curbing autophagy and histone deacetylases to kill cancer cells.

Gammoh N, Marks PA, Jiang X.

Autophagy. 2012 Oct;8(10):1521-2. doi: 10.4161/auto.21151. Epub 2012 Aug 16.

3.

TNFα-induced necroptosis and autophagy via supression of the p38-NF-κB survival pathway in L929 cells.

Ye YC, Yu L, Wang HJ, Tashiro S, Onodera S, Ikejima T.

J Pharmacol Sci. 2011;117(3):160-9. Epub 2011 Oct 25.

4.

Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.

Zhong HM, Ding QH, Chen WP, Luo RB.

Int Immunopharmacol. 2013 Oct;17(2):329-35. doi: 10.1016/j.intimp.2013.06.027. Epub 2013 Jul 13.

PMID:
23856614
5.

Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.

Gammoh N, Lam D, Puente C, Ganley I, Marks PA, Jiang X.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6561-5. doi: 10.1073/pnas.1204429109. Epub 2012 Apr 9.

6.

Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.

Yerbes R, López-Rivas A.

Invest New Drugs. 2012 Apr;30(2):541-7. doi: 10.1007/s10637-010-9597-x. Epub 2010 Nov 25.

PMID:
21107885
7.

Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.

Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.

Oncogene. 2007 Feb 22;26(8):1201-12. Epub 2006 Aug 21.

PMID:
16924232
8.

Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.

Kurundkar D, Srivastava RK, Chaudhary SC, Ballestas ME, Kopelovich L, Elmets CA, Athar M.

Toxicol Appl Pharmacol. 2013 Jan 15;266(2):233-44. doi: 10.1016/j.taap.2012.11.002. Epub 2012 Nov 9.

9.

SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.

Crawford N, Stasik I, Holohan C, Majkut J, McGrath M, Johnston PG, Chessari G, Ward GA, Waugh DJ, Fennell DA, Longley DB.

Cell Death Dis. 2013 Jul 18;4:e733. doi: 10.1038/cddis.2013.258.

10.

Suppression of caspase-11 expression by histone deacetylase inhibitors.

Heo H, Yoo L, Shin KS, Kang SJ.

Biochem Biophys Res Commun. 2009 Jan 2;378(1):79-83. doi: 10.1016/j.bbrc.2008.11.009. Epub 2008 Nov 21.

PMID:
19013432
11.

Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.

Chong W, Li Y, Liu B, Zhao T, Fukudome EY, Liu Z, Smith WM, Velmahos GC, deMoya MA, Alam HB.

J Surg Res. 2012 Dec;178(2):851-9. doi: 10.1016/j.jss.2012.07.023. Epub 2012 Jul 26.

12.

Akt Regulates TNFα synthesis downstream of RIP1 kinase activation during necroptosis.

McNamara CR, Ahuja R, Osafo-Addo AD, Barrows D, Kettenbach A, Skidan I, Teng X, Cuny GD, Gerber S, Degterev A.

PLoS One. 2013;8(3):e56576. doi: 10.1371/journal.pone.0056576. Epub 2013 Mar 1.

14.

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P, Donà G, Fossati G, Sozzani S, Azam T, Bufler P, Fantuzzi G, Goncharov I, Kim SH, Pomerantz BJ, Reznikov LL, Siegmund B, Dinarello CA, Mascagni P.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2995-3000. Epub 2002 Feb 26.

16.

Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma.

Liu YL, Yang PM, Shun CT, Wu MS, Weng JR, Chen CC.

Autophagy. 2010 Nov;6(8):1057-65.

17.
18.

Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.

Choi Y, Park SK, Kim HM, Kang JS, Yoon YD, Han SB, Han JW, Yang JS, Han G.

Exp Mol Med. 2008 Oct 31;40(5):574-81.

19.

MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells.

Manetsch M, Che W, Seidel P, Chen Y, Ammit AJ.

Cell Signal. 2012 Apr;24(4):907-13. doi: 10.1016/j.cellsig.2011.12.013. Epub 2011 Dec 19.

PMID:
22200679
20.

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.

Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O.

Blood. 2003 May 1;101(9):3451-9. Epub 2003 Jan 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk